
    
      Our study is a single arm, single center clinical trial. The enrolled patients will accept
      laparoscopic ileocecus-sparing right hemicolectomy. The primary endpoint: postoperative
      complications, 1-year local recurrence. The second endpoint: conversion to conventional right
      hemicolectomy, time to first flatus after surgery, number of harvested lymph nodes, 3-year
      disease free survival, R0 resection, Specimen morphometry
    
  